Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/19/2025

Respiratory Health Management

Introduction to Management

  • Smoking cessation is the most effective intervention, resulting in 90% cough resolution, as recommended by the American College of Chest Physicians 1, 2
  • Avoidance of all respiratory irritants is also recommended to improve respiratory health 1, 2

Diagnosis and Differentiation

  • Acute bronchitis is defined as an acute lower respiratory tract infection, manifested predominantly by cough with or without sputum production, lasting no more than 3 weeks, with no clinical or radiographic evidence suggesting an alternative explanation, according to the American College of Chest Physicians 3
  • The condition can be differentiated from pneumonia, asthma, COPD exacerbation, and common cold based on key characteristics, including acute cough with or without phlegm production lasting up to 3 weeks, normal chest radiograph, and absence of fever, tachycardia, tachypnea, or focal chest findings 4, 3, 5, 6
  • The following table summarizes the key characteristics of acute bronchitis and other related conditions:
Condition Characteristics
Acute Bronchitis Acute cough lasting up to 3 weeks, may include sputum production, normal chest radiograph, and absence of pneumonia, common cold, acute asthma, or COPD exacerbation
Pneumonia Fever, tachycardia, tachypnea, or focal chest findings
Asthma Wheezing, cough, shortness of breath
COPD Exacerbation Increased symptoms of COPD, such as cough, sputum production, and shortness of breath
Common Cold Rhinorrhea, sneezing, sore throat

Pharmacological Interventions

  • Short-acting β-agonists (e.g., albuterol) are recommended for patients with wheezing or bronchospasm, as stated by the American College of Chest Physicians 1, 5
  • Ipratropium bromide is used to improve cough, according to the American College of Chest Physicians 1
  • Long-acting β-agonist combined with inhaled corticosteroid is recommended for chronic cough control, as suggested by the American College of Chest Physicians 1
  • Inhaled corticosteroids are recommended for patients with significantly reduced lung function or frequent exacerbations, as stated by the American College of Chest Physicians 1, 2
  • Antitussives, such as codeine or dextromethorphan, may provide short-term symptomatic relief for troublesome cough (Grade C recommendation), as recommended by the American College of Chest Physicians and supported by 2, 6, 7, 5

Treatment of Acute Exacerbations

  • Inhaled bronchodilators, oral antibiotics (if at least two Anthonisen criteria are present), and a short course of oral corticosteroids (10-15 days) are recommended for acute exacerbations of chronic bronchitis 1
  • Antibiotics may be indicated for Acute Exacerbation of Chronic Bronchitis (AECB) when at least two Anthonisen criteria are present, including increased dyspnea, sputum volume, and purulence 8
  • Amoxicillin is the preferred antibiotic for bronchitis treatment, with cefalexina as an alternative only if there is no suspicion of Haemophilus influenzae infection 8
  • Macrolides, pristinamycin, or doxycycline may be used as alternatives in cases of beta-lactam allergy 8
  • Long-term prophylactic antibiotics are not recommended, as stated by the American College of Chest Physicians 1
  • Expectorants are not recommended due to lack of proven benefit, according to the American College of Chest Physicians 1
  • Postural drainage and chest percussion are not recommended, as stated by the American College of Chest Physicians 1
  • Theophylline is not recommended due to its side effects outweighing its benefits, according to the American College of Chest Physicians 1
  • Routine antibiotic treatment is not recommended for acute bronchitis, as stated by the American College of Emergency Physicians 6
  • Long-term prophylactic antibiotics and oral corticosteroids should be avoided due to lack of benefit and high risk of side effects, respectively, according to the American College of Chest Physicians 2

Patient Education and Follow-up

  • Patients should be advised to seek reassessment if cough persists beyond 3 weeks or worsens, new symptoms develop suggesting bacterial superinfection, or if the patient has underlying conditions that increase risk of complications, as recommended by the American College of Chest Physicians 3
  • Patients should be informed about the typical cough duration of 2-3 weeks, the viral nature of most cases, and the risks of unnecessary antibiotic use, as recommended by the American Academy of Family Physicians and supported by 6, 3, 9, 10
  • Refer to the condition as a "chest cold" rather than "bronchitis" to reduce antibiotic expectations, as suggested by the American Academy of Family Physicians 10
  • Patient satisfaction depends more on effective communication about the condition and expected recovery time than on receiving antibiotics, as noted by the American Academy of Family Physicians 10